“For more than 25 years, Alcon has been a leader in vitreoretinal surgery, and we are excited to expand our offerings into the clinic, to help millions of people living with dry AMD gain vision,” said ...
Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results